Hemo Organic Limited will hold a board meeting on September 23, 2026, to consider proposals for raising funds through various permissible modes. The company is exploring options including qualified institutions placement and preferential allotment.

The board aims to approve the issuance of equity shares or convertible securities for cash or other consideration. This move seeks to secure capital through mechanisms such as share swaps or rights issues, subject to necessary regulatory approvals.

Fund Raising Proposal Details

The agenda includes considering the issuance of equity shares and convertible securities, including convertible warrants. The company may raise funds in one or more tranches through:

• Preferential allotment
• Private placement
• Qualified institutions placement (QIP)
• Rights issue
• Further public issue

These actions require statutory approvals and consent from members. The board will also consider any ancillary actions required for such fund raising.

Trading Window Closure

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window remains closed. This restriction starts from business closing hours on September 19, 2026, and continues until 48 hours after the conclusion of the board meeting.

The disclosure was made pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ayush Dharmendrabhai Jasani, Chairman and Additional Director, signed the intimation letter addressed to BSE Limited.

Hemo Organic Limited shareholders appointed M/s. V S S B & Associates, Chartered Accountants, as the company's statutory auditor for a five-year term during its 34th annual general meeting on September 8, 2026.

The appointment follows the completion of the second term by the outgoing auditors, M/s M A A K & Associates, Chartered Accountants (FRN: 135024W). The new auditors, based in Ahmedabad and holding FRN 121356W, will serve from the conclusion of the 34th AGM until the conclusion of the 39th AGM.

AGM Outcomes

The virtual meeting, held on September 8, 2026, saw unanimous approval for all three ordinary resolutions proposed by the board. Shareholders voted via electronic means to ratify the financial position for the period ending September 1, 2026, which served as the record date.

In addition to the auditor appointment, shareholders approved:

• Adoption of the annual audited financial statements and reports thereon.
• Appointment of Mr Murlidhar Joshi (DIN: 09819849) as a director retiring by rotation.

Jitendra Parmar of Jitendra Parmar & Associates served as the scrutinizer, submitting his report on September 9, 2026.

Voting Participation

A total of 4,825 shareholders were on the register as on the record date. Only 21 shareholders attended the meeting through video conferencing or other audio-video means. This included two promoter group members and 19 public shareholders. No shareholders attended in person or through proxy.

Promoter entities held 583,940 shares and cast all their votes in favor of every resolution. Public non-institutional investors held 2,881,960 shares but polled only 6,715 votes, representing a turnout of 0.233%. No public institutional investors participated.